Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples